Editas Medicine (EDIT) Prepaid Assets (2015 - 2025)
Editas Medicine (EDIT) reported Prepaid Assets of $2.1 million for Q4 2025, down 33.86% year-over-year from $3.1 million in Q4 2024, and down 33.38% on a QoQ basis from $3.1 million in Q3 2025.
Editas Medicine (EDIT) has 11 years of Prepaid Assets data on file, last reported at $2.1 million in Q4 2025.
- Quarterly Prepaid Assets fell 33.86% year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (down 33.86% YoY) and the FY2025 annual result came in at $2.1 million, down 33.86% from the prior year.
- Prepaid Assets fell to $2.1 million in Q4 2025 per EDIT's latest filing, from $3.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $9.5 million in Q3 2021 and bottomed at $2.1 million in Q4 2025.
- The 5-year median for Prepaid Assets is $6.6 million (2023), against an average of $6.1 million.
- The widest annual swing landed in 2024, when Prepaid Assets jumped 58.2%; it then sank 63.14% in 2025.
- Tracing EDIT's Prepaid Assets over 5 years: stood at $7.2 million in 2021, then climbed by 1.9% to $7.3 million in 2022, then climbed by 2.67% to $7.5 million in 2023, then plunged by 58.36% to $3.1 million in 2024, then sank by 33.86% to $2.1 million in 2025.
- Per Business Quant, the three latest EDIT Prepaid Assets figures stand at $2.1 million (Q4 2025), $3.1 million (Q3 2025), and $3.7 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 3.11 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 5.93 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 9.14 Mn |
| Dec 31, 2023 | 7.53 Mn |
| Sep 30, 2023 | 6.56 Mn |
| Jun 30, 2023 | 6.72 Mn |
| Mar 31, 2023 | 5.78 Mn |
| Dec 31, 2022 | 7.34 Mn |
| Sep 30, 2022 | 6.89 Mn |
| Jun 30, 2022 | 8.11 Mn |
| Mar 31, 2022 | 7.30 Mn |
| Dec 31, 2021 | 7.20 Mn |
| Sep 30, 2021 | 9.52 Mn |
| Jun 30, 2021 | 5.41 Mn |
| Mar 31, 2021 | 6.31 Mn |
| Dec 31, 2020 | 10.93 Mn |
| Sep 30, 2020 | 10.47 Mn |
| Jun 30, 2020 | 9.54 Mn |
| Mar 31, 2020 | 8.28 Mn |
| Dec 31, 2019 | 6.29 Mn |
| Sep 30, 2019 | 6.28 Mn |
| Jun 30, 2019 | 6.30 Mn |
| Mar 31, 2019 | 5.00 Mn |
| Dec 31, 2018 | 5.79 Mn |
| Sep 30, 2018 | 5.02 Mn |
| Jun 30, 2018 | 3.80 Mn |
| Mar 31, 2018 | 3.06 Mn |
| Dec 31, 2017 | 2.38 Mn |
| Sep 30, 2017 | 2.03 Mn |
| Jun 30, 2017 | 2.26 Mn |
| Mar 31, 2017 | 1.29 Mn |
| Dec 31, 2016 | 1.66 Mn |
| Sep 30, 2016 | 2.45 Mn |
| Jun 30, 2016 | 2.37 Mn |
| Mar 31, 2016 | 1.87 Mn |
| Dec 31, 2015 | 786,000.00 |